These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 30365413)
1. The Effect of Rebamipide Ophthalmic Solution on Cytokine and Mucin Secretion in Culture of Conjunctival Epithelial Cells From the Cu, Zn-Superoxide Dismutase-1 (SOD-1) Knock-Down Mouse. Ogawa M; Simsek C; Kojima T; Nagata T; Igarashi A; Kawakita T; Dogru M; Shimazaki J; Tsubota K Eye Contact Lens; 2019 Mar; 45(2):93-98. PubMed ID: 30365413 [TBL] [Abstract][Full Text] [Related]
2. The effects of 2% rebamipide ophthalmic solution on the tear functions and ocular surface of the superoxide dismutase-1 (sod1) knockout mice. Ohguchi T; Kojima T; Ibrahim OM; Nagata T; Shimizu T; Shirasawa T; Kawakita T; Satake Y; Tsubota K; Shimazaki J; Ishida S Invest Ophthalmol Vis Sci; 2013 Nov; 54(12):7793-802. PubMed ID: 24168989 [TBL] [Abstract][Full Text] [Related]
3. The Role of 2% Rebamipide Eye Drops Related to Conjunctival Differentiation in Superoxide Dismutase-1 (Sod1) Knockout Mice. Kojima T; Simsek C; Igarashi A; Aoki K; Higa K; Shimizu T; Dogru M; Tsubota K; Shimazaki J Invest Ophthalmol Vis Sci; 2018 Mar; 59(3):1675-1681. PubMed ID: 29625494 [TBL] [Abstract][Full Text] [Related]
4. Rebamipide suppresses PolyI:C-stimulated cytokine production in human conjunctival epithelial cells. Ueta M; Sotozono C; Yokoi N; Kinoshita S J Ocul Pharmacol Ther; 2013 Sep; 29(7):688-93. PubMed ID: 23662915 [TBL] [Abstract][Full Text] [Related]
5. Comparison of Ocular Surface Mucin Expression After Topical Ophthalmic Drug Administration in Dry Eye-Induced Mouse Model. Moon I; Kang HG; Yeo A; Noh H; Kim HC; Song JS; Ji YW; Lee HK J Ocul Pharmacol Ther; 2018 Nov; 34(9):612-620. PubMed ID: 30325678 [TBL] [Abstract][Full Text] [Related]
6. Secreted Mucins on the Ocular Surface. Hori Y Invest Ophthalmol Vis Sci; 2018 Nov; 59(14):DES151-DES156. PubMed ID: 30481820 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Short-Term Effects of Diquafosol and Rebamipide on Mucin 5AC Level on the Rabbit Ocular Surface. Hori Y; Kageyama T; Sakamoto A; Shiba T; Nakamura M; Maeno T J Ocul Pharmacol Ther; 2017; 33(6):493-497. PubMed ID: 28346860 [TBL] [Abstract][Full Text] [Related]
8. Rebamipide suppresses TNF-α production and macrophage infiltration in the conjunctiva. Tajima K; Hattori T; Takahashi H; Katahira H; Narimatsu A; Kumakura S; Goto H Vet Ophthalmol; 2018 Jul; 21(4):347-352. PubMed ID: 29251403 [TBL] [Abstract][Full Text] [Related]
9. Rebamipide increases the amount of mucin-like substances on the conjunctiva and cornea in the N-acetylcysteine-treated in vivo model. Urashima H; Okamoto T; Takeji Y; Shinohara H; Fujisawa S Cornea; 2004 Aug; 23(6):613-9. PubMed ID: 15257002 [TBL] [Abstract][Full Text] [Related]
10. Effects of Oxidative Stress on the Conjunctiva in Cu, Zn-Superoxide Dismutase-1 (Sod1)-Knockout Mice. Kojima T; Dogru M; Ibrahim OM; Wakamatsu TH; Ito M; Igarashi A; Inaba T; Shimizu T; Shirasawa T; Shimazaki J; Tsubota K Invest Ophthalmol Vis Sci; 2015 Dec; 56(13):8382-91. PubMed ID: 26747769 [TBL] [Abstract][Full Text] [Related]
11. Preparation of an Ultrafine Rebamipide Ophthalmic Suspension with High Transparency. Matsuda T; Hiraoka S; Urashima H; Ogura A; Ishida T Biol Pharm Bull; 2017; 40(5):665-674. PubMed ID: 28458352 [TBL] [Abstract][Full Text] [Related]
12. The inhibitory effects of rebamipide on cigarette smoke-induced airway mucin production. Lee SY; Kang EJ; Hur GY; Jung KH; Jung HC; Lee SY; Kim JH; Shin C; In KH; Kang KH; Yoo SH; Shim JJ Respir Med; 2006 Mar; 100(3):503-11. PubMed ID: 16039106 [TBL] [Abstract][Full Text] [Related]
14. Diesel exhaust particles selectively induce both proinflammatory cytokines and mucin production in cornea and conjunctiva human cell lines. Tau J; Novaes P; Matsuda M; Tasat DR; Saldiva PH; Berra A Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4759-65. PubMed ID: 23722391 [TBL] [Abstract][Full Text] [Related]
15. Rebamipide increases mucin-like substance contents and periodic acid Schiff reagent-positive cells density in normal rabbits. Urashima H; Takeji Y; Okamoto T; Fujisawa S; Shinohara H J Ocul Pharmacol Ther; 2012 Jun; 28(3):264-70. PubMed ID: 22304618 [TBL] [Abstract][Full Text] [Related]
16. Effects of Exposure to Ozone on the Ocular Surface in an Experimental Model of Allergic Conjunctivitis. Lee H; Kim EK; Kim HY; Kim TI PLoS One; 2017; 12(1):e0169209. PubMed ID: 28046113 [TBL] [Abstract][Full Text] [Related]
17. Size effect of rebamipide ophthalmic nanodispersions on its therapeutic efficacy for corneal wound healing. Nagai N; Ito Y; Okamoto N; Shimomura Y Exp Eye Res; 2016 Oct; 151():47-53. PubMed ID: 27423550 [TBL] [Abstract][Full Text] [Related]
18. Secretion of proinflammatory cytokines by human conjunctival epithelial cells. Gamache DA; Dimitrijevich SD; Weimer LK; Lang LS; Spellman JM; Graff G; Yanni JM Ocul Immunol Inflamm; 1997 Jun; 5(2):117-28. PubMed ID: 9234376 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness and relevant factors of 2% rebamipide ophthalmic suspension treatment in dry eye. Ueda K; Matsumiya W; Otsuka K; Maeda Y; Nagai T; Nakamura M BMC Ophthalmol; 2015 Jun; 15():58. PubMed ID: 26048396 [TBL] [Abstract][Full Text] [Related]
20. Effect of rebamipide ophthalmic suspension on signs and symptoms of keratoconjunctivitis sicca in Sjögren syndrome patients with or without punctal occlusions. Arimoto A; Kitagawa K; Mita N; Takahashi Y; Shibuya E; Sasaki H Cornea; 2014 Aug; 33(8):806-11. PubMed ID: 24977983 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]